Target intelligence / Profile preview

Phospholipid-transporting ATPase IC (ATP8B1)

Target
ATP8B1
Molecular classification
Enzyme, Transporter, P4-ATPase (lipid flippase), Membrane protein
01

Overview

Phospholipid-transporting ATPase IC (ATP8B1) is a critical membrane enzyme of the P4-ATPase family, known as a "lipid flippase." It catalyzes the ATP-dependent translocation of aminophospholipids, especially phosphatidylserine and phosphatidylcholine, from the exoplasmic to the cytosolic leaflet of biological membranes, preserving membrane asymmetry essential for cellular integrity, vesicle formation, protein targeting, and bile secretion. It functions as an obligate heterodimer with CDC50A, a non-catalytic subunit required for ER exit and flippase activity. ATP8B1 is most studied in the liver, where it maintains canalicular membrane integrity during bile acid transport; mutations cause progressive familial intrahepatic cholestasis type 1 (PFIC1) and BRIC1, severe genetic diseases resulting in impaired bile flow and liver dysfunction. ATP8B1 is also critical for vesicular trafficking in other tissues and may have broader roles in cellular homeostasis and disease susceptibility, including possible links to neurodegeneration.

Other names
Familial intrahepatic cholestasis type 1FIC1BRIC1P4-ATPase flippase complex alpha subunit ATP8B1PFIC1probable phospholipid-transporting ATPase ICATPICBRICICP1aminophospholipid transporter class I type 8B member 1E1-E2 ATPase
02

Mechanism of action

Drugs influencing ATP8B1 function would likely alter its aminophospholipid flippase activity, affecting the distribution of phosphatidylserine and possibly other phospholipids; perifosine uptake is one described mechanism. Potential restoration or modulation of membrane lipid asymmetry, especially in the context of hepatobiliary diseases.

03

Biological functions

Maintenance of membrane phospholipid asymmetryTransport of phospholipids (notably phosphatidylserine and phosphatidylcholine) across the plasma membrane (from exoplasmic to cytosolic leaflet)Regulation of bile acid transport and membrane integrity in hepatocytesVesicle biogenesis and protein traffickingLysosomal fusion and endolysosomal degradationRegulation of membrane protein targeting and activity
04

Disease associations

Liver diseases, specifically progressive familial intrahepatic cholestasis type 1 (PFIC1)Benign recurrent intrahepatic cholestasis type 1 (BRIC1)Disorders of bile acid transportPotential link to neurodegenerative disease (evidence in resilience to Alzheimer’s disease)Other disorders associated with membrane homeostasis
05

Safety considerations

Loss-of-function mutations lead to severe liver pathology (intrahepatic cholestasis, liver failure), particularly in pediatric populationsAltered membrane integrity may affect other tissues, as ATP8B1 has broad expression, including in the heart and brainImpaired vesicle trafficking and lysosomal degradation could impact cellular homeostasis, with potential multi-system effects
06

Interacting drugs

Perifosine
07

Biomarkers

Genetic testing for ATP8B1 mutations (used in diagnosis of PFIC1 and BRIC1)Monitoring bile acid levels or markers of cholestasis in liver disease

Beyond the preview

Go deeper on Phospholipid-transporting ATPase IC (ATP8B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipid-transporting ATPase IC (ATP8B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call